Page 4 - உலகளாவிய ஆரோக்கியம் தொழில்நுட்பங்கள் கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U S Congress has clear opportunity to supercharge global health R&D, shows report

U S Congress has clear opportunity to supercharge global health R&D, shows report
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

United statesWhite houseDistrict of columbiaEmily hendersonWalter reed army institute of researchNaval medical research centerUs congressUs centers for diseaseTuberculosis trials consortiumNational institute of allergyCoalition for epidemic preparedness innovationsGlobal health technologies coalitionOxford universityDepartment of defense doNational centerBiomedical advanced research

Seeking a Path Forward in a Post-Pandemic World, New Report Reveals How the U S Can Renew its Leadership in Global Health R&D

Seeking a Path Forward in a Post-Pandemic World, New Report Reveals How the U S Can Renew its Leadership in Global Health R&D
ghtcoalition.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghtcoalition.org Daily Mail and Mail on Sunday newspapers.

United statesWhite houseDistrict of columbiaWalter reed army institute of researchNaval medical research centerUs congressUs centers for diseaseTuberculosis trials consortiumNational institute of allergyGlobal health technologies coalitionCoalition for epidemic preparedness innovationsOxford universityDepartment of defense doNational centerBiomedical advanced researchNational institutes of health

New report reveals how the U S can renew its leadership in global health R&D

E-Mail The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by the nonprofit Global Health Technologies Coalition (GHTC). The same core capabilities instrumental to defeating COVID-19 can also defeat diseases that have plagued humanity for generations such as AIDS, tuberculosis, malaria and Ebola while targeting emerging pathogens of pandemic potential, said GHTC Director Jamie Bay Nishi. Developing vaccines in such record-breaking time is, in reality, the product of decades of R&D investments. With smart funding and policy decisions, this foundation can generate a new era of innovations that will protect the health of millions of Americans and billions of people around the world.

United statesWhite houseDistrict of columbiaWalter reed army institute of researchNaval medical research centerUs congressUs centers for diseaseTuberculosis trials consortiumNational institute of allergyGlobal health technologies coalitionCoalition for epidemic preparedness innovationsOxford universityDepartment of defense doNational centerBiomedical advanced researchNational institutes of health

GHTC delivers statement on antimicrobial resistance at WHO Executive Board meeting

GHTC delivers statement on antimicrobial resistance at WHO Executive Board meeting The following statement from Global Health Council, supported by the Global Health Technologies Coalition and the Infectious Diseases Society of America was delivered at the 148th session of the WHO Executive Board on Agenda Item 9: Antimicrobial resistance. The Global Health Council, Global Health Technologies Coalition, and Infectious Diseases Society of America thank the chair and distinguished delegates for this opportunity to comment on the ongoing work against resistance to antimicrobials from a large span of bacterial, viral, parasitic, and fungal microorganisms. According to a recent Lancet study, bacterial infections unsuccessfully treated due to antimicrobial resistance (AMR) claim at least 700,000 lives per year worldwide and are projected to be associated with the deaths of 10 million people per year by 2050.

United statesGlobal antibiotic researchGlobal health councilWorld health organizationDevelopment partnershipInfectious diseases society of americaGlobal health technologies coalitionInfectious diseases societyAgenda itemGlobal antimicrobial resistanceUse surveillance systemஒன்றுபட்டது மாநிலங்களில்உலகளாவிய நுண்ணுயிர்க்கொல்லி ஆராய்ச்சிஉலகளாவிய ஆரோக்கியம் சபைஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்வளர்ச்சி கூட்டு

GHC Statement on Immunization Agenda 2030 at the 148th Session of the WHO Executive Board

GHC Statement on Immunization Agenda 2030 at the 148th Session of the WHO Executive Board January 25, 2021 The following statement from Global Health Council, supported by the Global Health Technologies Coalition and the Infectious Diseases Society of America was submitted to the 148th session of the WHO Executive Board on Agenda Item 12: Immunization Agenda 2030. The Global Health Council, Global Health Technologies Coalition, and the Infectious Diseases Society of America commend the World Health Organization (WHO) and member states on progress made toward achieving global immunization targets. Despite these efforts, coverage of essential vaccines only increased from 84 percent in 2010 to 86 percent in 2018, leaving nearly 20 million children unvaccinated every year. Polio has not been eradicated, and the COVID-19 pandemic threatens to undo decades worth of progress. Dozens of countries have reported disruptions to vital immunization programs, including at least 30 me

United statesGlobal health councilWorld health organizationInfectious diseases society of americaGlobal health technologies coalitionInfectious diseases societyAgenda itemImmunization agendaஒன்றுபட்டது மாநிலங்களில்உலகளாவிய ஆரோக்கியம் சபைஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்தொற்று நோய்கள் சமூகம் ஆஃப் அமெரிக்காஉலகளாவிய ஆரோக்கியம் தொழில்நுட்பங்கள் கூட்டணிதொற்று நோய்கள் சமூகம்